Sheel Biotech Clarifies IPO Fund Utilization for Half-Year Ended Mar'26
Sheel Biotech Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 11:50 pm
Sheel Biotech Clarifies IPO Fund Utilization for Half-Year Ended Mar'26 Sheel Biotech confirmed zero deviations in its IPO fund utilization for the half-year ended Mar'26. Of the Rs. 3,402.00 Lakhs raised, the company utilized Rs. 3,128.37 Lakhs, allocating Rs. 1,588.00 Lakhs to working capital, Rs. 665.95 Lakhs for blueberry greenhouse capex, and Rs. 472.17 Lakhs for general corporate purposes. The unutilized balance of Rs. 273.63 Lakhs remains deployed in fixed deposits. Statutory auditor certificates validate this deployment, resolving any potential market misinterpretation regarding the company's capital allocation execution.
Original exchange filing (PDF)
More announcements from Sheel Biotech Ltd
- Sheel Biotech Limited has informed the Exchange regarding 'Investor Presentation'. 路 17 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Monitoring Agency Report for the Half year ended on 30th September, 2026. 路 13 Nov 2026
- SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 13 Nov 2026
- Sheel Biotech Limited has informed the Exchange about receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production. 路 30 Oct 2026
- Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026. 路 14 Oct 2026
